Diagnostics & Diseases Market Research Reports & Industry Analysis

Complete report $6,700. DataPack (test volumes, sales forecasts, supplier shares) $4,350. New Frontiers in the Italian Cancer Diagnostics Market: Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Groups new study of the major business opportunities emerging in the Italian ...

Complete report $8,800. DataPack (test volumes, sales forecasts, supplier shares) $5,700. New Frontiers in the Japanese Cancer Diagnostics Market: Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Groups new study of the major business opportunities emerging in the ...

Complete report $6,700. DataPack (test volumes, sales forecasts, supplier shares) $4,350. New Frontiers in the Spanish Cancer Diagnostics Market: Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Groups new study of the major business opportunities emerging in the Spanish ...

Complete report $6,700. DataPack (test volumes, sales forecasts, supplier shares) $4,350. New Frontiers in the UK Cancer Diagnostics Market: Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Groups new study of the major business opportunities emerging in the UK cancer ...

Complete report $9,800. DataPack (test volumes, sales forecasts, supplier shares) $6,400. New Frontiers in the U.S. Cancer Diagnostics Market: Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Groups new study of the major business opportunities emerging in the U.S. cancer ...

... . DataPack (test volumes, sales forecasts, supplier shares) $21,100. New Frontiers in Cancer Diagnostics: Global Challenges, Emerging Technologies, Competitive Landscape is Venture ... specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer ...

Complete report $19,700. DataPack (test volumes, sales forecasts, supplier shares) $12,800. New Frontiers in the European Cancer Diagnostics Market: Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Groups new study of the major business opportunities emerging in the ...

... early access to a new cancer product, but a number of developers have also highlighted notable benefits derived from the process. To assess the view of expanded access programmes from the position of the physician community, FirstWord is polling oncologists based in the ...

... have their own particular views on how this resource can be used to improve the treatment of patients in the future? Are they aware of the ... physician perceptive towards real-world data, FirstWord polled 192 oncologists based in the US and EU5. Specifically we asked them How aware they are ...

The report presents a comprehensive analysis of the clinical significance and market needs for major blood typing, grouping, and infectious disease screening assays, including NAT tests, as well as extensive listings of companies developing or marketing new blood banking technologies and products. Contains ...

... market entrants identify and evaluate emerging opportunities in the European molecular blood banking market during the next five years, and ... , by test. Strategic Recommendations New product development opportunities for molecular blood typing, grouping and infectious disease NAT assays and instrumentation ...

... market entrants identify and evaluate emerging opportunities in the Italian molecular blood banking market during the next five years, and ... Laboratories Current and Emerging Products Analysis of current and emerging blood typing, grouping and Infectious Disease Screening Tests. Review of automated and ...

... market entrants identify and evaluate emerging opportunities in the Japanese molecular blood banking market during the next five years, and ... Laboratories Current and Emerging Products Analysis of current and emerging blood typing, grouping and Infectious Disease Screening Tests. Review of automated and ...

... potential market entrants identify and evaluate emerging opportunities in the UK molecular blood banking market during the next five years, and ... Laboratories Current and Emerging Products Analysis of current and emerging blood typing, grouping and Infectious Disease Screening Tests. Review of automated ...

... and potential market entrants identify and evaluate emerging opportunities in the US molecular blood banking market during the next five years, and ... Blood Banks Current and Emerging Products Analysis of current and emerging blood typing, grouping and Infectious Disease Screening Tests. Review of automated ...

... represents a paradigm shift compared to the protease inhibitors and interferon regimens. With convenient, efficacious and safer therapies coming through the ... will shape the future market. Key Benefits Therapy Trends: Hepatitis C -- Game changing regimens to revolutionise treatment landscape examines the most prominent insights gained ...

... are as follows 1. United Kingdom 2. France 3. Germany 4. Italy 5. Spain 6. Sweden 7. Switzerland 8. Norway 9. Netherlands 10. United States 11. Canada 12. Japan 13. Korea 14. Singapore 15. Malaysia 16. Australia 17. India 18. China 19. Thailand 20. Indonesia Data Sources This report is built using data ...

... rising demand for POCT and technological advancements in the global market, the IVD market is going through a very exciting phase. Presently, the ... likely to witness strong growth in the coming years. In the latest research study, “Global In-Vitro Diagnostics Market Forecast to 2018”, RNCOS analysts identified ...

... KOL analysis of NSCLC treatments, development and competition, KOL Insight: Non-small cell lung cancer is an essential tool for keeping abreast of events that will shape ... Developments in the treatment of NSCLC are progressing rapidly. In KOL Insight: Non-small cell lung cancer, you will: Gain an invaluable overview into the most dynamic ...

... of Oncology Therapeutics in Gene Therapy Current Applications of Gene Therapy to Cancer Treatment Favorable Parameters for Cancer Gene Therapy Issued Involved with Application of Gene Therapy in Cancer Patients Regulatory Scenario for Gene Therapy Market Cancer Gene Therapy Drug Clinical ...

... over the next six years. The professional diagnostic products dominated the overall IVD market in 2013, owing to the high ... global IVD market on the basis of product and region: IVD Market Product Outlook Molecular Diagnostics Tissue Diagnostics Diabetes Monitoring Professional Diagnostics IVD Market Regional ...

This new report from Venture Planning Group provides strategic assessments of major blood banking product suppliers and emerging market entrants. The report presents analyses of major current and emerging suppliers in terms of their sales, market shares, product portfolios, marketing tactics, technological ...

... new report from Venture Planning Group provides strategic assessments of major suppliers of infectious deisease instuments and reagants, as well as emerging market entrants. The report presents strategic assessments of leading market players and emerging suppliers with innovative technologies and products in ...

... chemistry and immunodiagnostic product suppliers and emerging market entrants.The report presents strategic profiles of 25 current and emerging suppliers of clinical chemistry and immunodiagnostic products, including their sales, market shares, product portfolios, marketing tactics, technological know-how, ...

This new report from Venture Planning Group provides strategic assessments of major suppliers of hematology and flow cytometry instuments and reagants, as well as emerging market entrants. The report presents strategic analyses of the major current and emerging suppliers in terms of their sales, product ...

This new 90-page report from Venture Planning Group provides insightful profiles of leading microbiology market players and recent market entrants. The report presents strategic assessments, including sales, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative ...

... and the exponential decline in cost of whole genome sequencing. Our report entitled “US Personalized Cancer Genome Sequencing Market Outlook 2018” entails detailed ... in males and females. Further, we have provided potential states for whole genome sequencing to help market players gauge maximum opportunity for ...

This new report from Venture Planning Group provides analyses of 100 major and emerging suppliers of immunodiagnositcs, microbiology, cancer diagnostic, molecular diagnostic, hematology, coagulation and blood banking instruments and reagents. The report presents strategic profiles of 100 major and emerging ...

This new report from Venture Planning Group provides strategic assessments of leading and emerging flow cytometry market players. The report presents strategic analyses of major current and emerging manufacturers of flow cytometry analyzers and consumables in terms of their sales, product portfolios, ...

This new report from Venture Planning Group provides extensive analyses of major current and emerging suppliers of transfusion diagnostic instruments and reagents. The assessments include: Sales Product portfolios Marketing tactics Technological know-how New products in R&D Collaborative arrangements ...

This new 80-page report from Venture Planning Group provides insightful analyses of major current and emerging suppliers of tumor marker diagnostic instruments and reagents. The assessments include: Sales Product portfolios Distribution tactics Technological know-how New products in R&D Collaborative ...

This new report from Venture Planning Group provides strategic assessments of major cancer diagnostic product suppliers and emerging market entrants. The report presents strategic analyses of major current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product ...

This new report from Venture Planning Group provides strategic assessments of major coagulation product suppliers and emerging market entrants. The report presents analyses of major manufacturers of coagulation products in terms of their sales, market shares, product portfolios, marketing tactics, ...

This new report from Venture Planning Group provides strategic assessments of major suppliers of hemostasis diagnostic products, as well as emerging market entrants. The report presents analyses of major current and emerging suppliers of hemostasis instruments ans reagents, including: Sales estimates Market ...

... term: battle lines are drawn The fundamental drivers of the global diabetes market are strong and continue to fuel growth. Rising levels ... comprehensive FirstWord research is available in two comprehensive modules: The KOL Insight: Diabetes module provides a complete review and is enhanced with exclusive ...

This report provides an overview of the UK coagulation testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts by market segment. Contains 25 pages and 4 tables

This new 98-page report from Venture Planning Group provides insightful profiles of leading microbiology market players and recent market entrants. The assessments include sales, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements, and business ...

... as chemistry and hematology. The slow acceptance of the technology is in part due to the complexity of developing automation suitable for microbiology tests. The introduction of automated microbiology instrumentation has been delayed by a number of intrinsic and technical problems. The diffusion of automated ...

... opinion This new KOL Insight report Breast Cancer –new targeted therapies transform treatment provides everyone interested in this dynamic cancer sector with a complete understanding of the targeted products ... and weaknesses of currently available targeted therapies for breast cancer Assess how prescribing trends will change with launch of new products Identify promising late-stage ...

... looking to enter the highly lucrative Indian NIPT market. In their latest research study “Emerging Indian NIPT Market”, RNCOS analysts have identified various ... done between September-December 2012 with around 100 leading gynecologists in India. The key findings reveal that currently the awareness level of ...

This new report from Venture Planning Group provides an overview of the French diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments: Blood Banking Cancer Chemistry Coagulation ...

This new report from Venture Planning Group provides an overview of the German diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments: Blood Banking Cancer Chemistry Coagulation ...

This new report from Venture Planning Group provides an overview of the Italian diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments: Blood Banking Cancer Chemistry Coagulation ...

This new report from Venture Planning Group provides an overview of the Japanese diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments: Blood Banking Cancer Chemistry ...

This new report from Venture Planning Group provides an overview of the Spanish diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments: Blood Banking Cancer Chemistry Coagulation ...

This new report from Venture Planning Group provides an overview of the UK diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments: Blood Banking Cancer Chemistry Coagulation ...

This new report from Venture Planning Group provides an overview of the US diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments: Blood Banking Cancer Chemistry Coagulation ...

... current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Business opportunities and strategic recommendations for suppliers. Contains 997 pages and 87 tables

... current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Business opportunities and strategic recommendations for suppliers. Contains 897 pages and 77 tables

... current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Business opportunities and strategic recommendations for suppliers. Contains 897 pages and 74 tables